Atria Investments’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
CPBTD
NAM
PCTC
VCM
Atria Investments's ACLS Position: Q3 2026 in Review
Atria Investments sold out of Axcelis (ACLS) in Q3 2026, closing a stake of 3,666 shares — an estimated $695K sold.
Atria Investments first reported a position in ACLS in Q1 2026 and held it in 2 quarters. The position peaked at $695K in Q2 2026. 23 funds tracked by Wall St. Rank hold ACLS as of Q3 2026.
- Atria Investments reported no remaining Axcelis position as of Q3 2026 after selling out during the quarter.
- Atria Investments sold 3,666 Axcelis shares in Q3 2026, an estimated $695K.
- Atria Investments first reported a position in Axcelis in Q1 2026 and held it in 2 quarters.
- Atria Investments's Axcelis position peaked at $695K in Q2 2026.
- 23 funds tracked by Wall St. Rank held Axcelis as of Q3 2026.
Based on Atria Investments's 13F filing for Q3 2026, filed 15 Oct 2026.